ACE2 and COVID-19: The angiotensin‐converting enzyme 2 (ACE2) plays a crucial role in SARS‐CoV‐2 pathogenesis by allowing the virus to enter host cells.[130] Nevertheless, CD24 can inhibit the NF‐κB pathway and restrain it from secreting pro‐inflammatory cytokines, suggesting that CD24 is a potential immune target in COVID‐19.